Mr. Gallagher, MBA, CFA, is an accomplished healthcare and capital markets executive and investor with a distinguished record of success in both the public and private markets. He has over 25 years of life-science experience on Wall Street and in industry. Mr. Gallagher serves as Managing Director of Laidlaw Venture Partners and Senior Managing Director and head of healthcare institutional sales at Laidlaw & Co. (UK) Ltd. Pat is CEO of Voltron Therapeutics, which is developing a novel Self Assembling Vaccine technology in a variety of indications, including in Oncology and emerging Infectious Diseases. He also is CEO of PD Theranostics, which is optimizing and standardizing its proprietary prognostic imaging workflows and predictive artificial intelligence (AI) algorithms to enhance existing pathology results and provide predictive data designed to drive clinical decisions. Mr. Gallagher serves as a strategic consultant for Athenex, Inc., a biopharmaceutical firm focused on next-generation therapies in oncology and immunology. He also is treasurer of AerWave Medical and sits on the board of directors at Algorithm Sciences, Cingulate Therapeutics, and Evermore Global Advisors, a global money manager. Mr. Gallagher co-founded BDR Research Group, LLC, an independent sell-side research firm specializing in healthcare investing, financing and operations, and served as its chief executive officer.